Follow Us
Fertility Care > Revosit

 Revosit sachet 
 The below information is only for patients prescribed REVOSIT by Doctors. Please discuss with your Doctors for more information.

 Myo-Inositol,  D-Chiroinositol 
L-Carnitine,  Coenzyme -Q10,
L-Methyl Folate, 
Selenium &  

 Female Formula helps in Infertility / PCOS (Poly-Cystic Ovarian Syndrome)

  • As an Anti Oxidant therapy for Oxidative Stress to Improve Egg & Oocyte quality 
  • Helps restore Menstrual Cycle & Ovarian Activity in PCOS Patients 
  • Helps PCOS Patients to improve Insulin Sensitivity, Improved Glucose Tolerance and Decreased Glucose Stimulated Insulin Release 
  • Helps restore Hormonal Balance
  • Helps prepare patients undergoing Multiple Follicular Stimulation for IVF 

The process of ovulation involves a complex interaction of many different hormones. If one or more of these hormones is out of balance, you may experience an irregular cycle or infrequent ovulation, thereby increasing the length of time it takes to achieve pregnancy.

REVOSIT is made of naturally occurring substances which plays a key role in bringing body conditions right for achieving Pregnancy. Revosit acts as an insulin-sensitizing agent, helps to promote proper utilization of the hormone insulin, which in turn supports proper hormone balance, ovarian function, egg quality and menstrual cycle regularity.

PCOS and Infertility

Polycystic ovary syndrome (PCOS) is the most common cause of infertility which results in Ovarian dysfunction and Menstrual irregularity affecting around 20% of women in reproductive age. 

PCOS in women often lead to the folllowing conditions:

(1) Oligoovulation- and/or Anovulation;
(2) Clinical and/or biochemical signs of Hyperandrogenism that may be associated with Hirsutism
(3) Polycystic ovaries. 
Other features of PCOS are Acne, Seborrhoea, Obesity, Insulin resistance, Impaired glucose tolerance and Type 2 diabetes mellitus, Dyslipidaemia, Cardiovascular disease and Infertility.
Furthermore, endocrine and metabolic alterations such as Elevated serum concentrations of Testosterone, Insulin, luteinizing Hormone (LH) and Prolactin are prevalent in PCOS population. These may have a profound implication for the long term health of patients.

Revosit is a specially researched and developed formulation to help infertiltiy in women caused due to PCOS or Oxidative Stress.  Revosit combines clinically proven ingredients which are natural and safe to help support patients to achieve the followings.

  • Improved Ovarian function
  • Nomalize Menstrual Cycle
  • Improve Quality of Egg 
Myo-Inositol & D-Chiroinositol:

Myo-Inositol is naturally found in human tissues and a variety of food sources which include unprocessed grains (oats, wheat germ and bran), fresh citrus fruits (except lemons), cantaloupe, brewer’s yeast, unrefined molasses, liver, lima beans, raisins, peanuts, cabbage and lecithin.
 MYO are known as insulin-sensitizing agents for women with PCOS. When insulin levels are balanced, the body is better able to regulate overall reproductive function, including
  • hormone balance, ovarian function, egg quality and the menstrual cycle
Presentation:  Revosit is available in powder form, comes in Sachets. 
Dose: 1 to 2 sachet per day or as directed by your Doctor. 
Direction: Mix entire sachet in water, stir well and drink.  Revosit comes in tasty orange flavour. 
Availability:  Revosit is only available in selected clinics in Singapore. Please talk to your Doctors or call Haldane Pharmaceuticals at (65) 63330063 for more info.
This page provides general health information, it should not take the place of medical advice. We encourage you to talk to your healthcare providers (Doctor, Registered dietitian, Pharmacist, etc.) about your interest in, questions about, or use of dietary supplements and what may be best for your overall health. 
Updated: Nov, 2016
Myo­inositol ­ Support ovarian function and egg quality­naturally! (n.d.). Retrieved May 21, 2015, from­inositol.html?gclid=CJunotGJ0cUCFQaPaQodUIUABA 5. Nestler, J., Jakubowicz, D., Reamer, P., Gunn, R., & Allan, G. (1999, April 29). Ovulatory and Metabolic Effects of d­Chiro­Inositol in the Polycystic Ovary Syndrome — NEJM. Retrieved May 24, 2015, from 6. Nordio, M., & Proietti, E. (2012, May 16). The combined therapy with myo­inositol and D­chiro­inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo­inositol supplementation alone. Retrieved May 24, 2015, from 7. Tais, S. (2013, August 1). Myo­Inositol in Polycystic Ovarian Syndrome. Retrieved May 21, 2015, from­08/myo­inositol­polycystic­ovarian­syndrome 8. Unfer, V., Carlomagno, G., Dante, G., & Facchinetti, F. (2012). Effects of myo­inositol in women with PCOS: A systematic review of randomized controlled trials. Retrieved May 21, 2015



Copyright © 2014 - Haldane Pharmaceuticals Pte Ltd
Design and Developed by  and Innovatedmedia